Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBT: 2010-2016

Historic EBT for Tenax Therapeutics (TENX) over the last 3 years, with Dec 2016 value amounting to -$42.2 million.

  • Tenax Therapeutics' EBT fell 248.86% to -$42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$64.5 million, marking a year-over-year increase of 51.87%. This contributed to the annual value of -$17.6 million for FY2024, which is 126.43% down from last year.
  • Tenax Therapeutics' EBT amounted to -$42.2 million in Q4 2016, which was down 838.19% from -$4.5 million recorded in Q3 2016.
  • Over the past 5 years, Tenax Therapeutics' EBT peaked at -$1.6 million during Q4 2012, and registered a low of -$118.0 million during Q2 2013.
  • For the 2-year period, Tenax Therapeutics' EBT averaged around -$16.1 million, with its median value being -$8.9 million (2015).
  • The largest annual percentage gain for Tenax Therapeutics' EBT in the last 5 years was 66.56% (2013), contrasted with its biggest fall of 4,393.38% (2013).
  • Quarterly analysis of 4 years shows Tenax Therapeutics' EBT stood at -$1.6 million in 2012, then tumbled by 4,393.38% to -$118.0 million in 2013, then reached -$12.1 million in 2015, then plummeted by 248.86% to -$42.2 million in 2016.
  • Its EBT was -$42.2 million in Q4 2016, compared to -$4.5 million in Q3 2016 and -$5.7 million in Q2 2016.